SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+15.1%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
(-45%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-112.71%
Top 10 Holdings %
Top 10 Hldgs %
92.32%
Holding
24
New
8
Increased
4
Reduced
7
Closed
4
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$9.72M |
| 2 |
Galapagos
GLPG
|
$4.24M |
| 3 |
Nektar Therapeutics
NKTR
|
$3.25M |
| 4 |
Milestone Pharmaceuticals
MIST
|
$2.62M |
| 5 |
scPharmaceuticals
SCPH
|
$2.24M |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$38.3M |
| 2 |
Evolus
EOLS
|
$37.2M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
$36.8M |
| 4 |
QuidelOrtho
QDEL
|
$33.2M |
| 5 |
Xeris Biopharma Holdings
XERS
|
$11.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Evolus
EOLS
$494M
| $37.4M | 29.7% | 2,674,356 -2,658,648 | -50% | -$37.2M |
|
|
2
ADMA Biologics
ADMA
$4.12B
| $22.6M | 17.94% | 3,426,882 -5,795,735 | -63% | -$38.3M |
|
|
ALIM
3
DELISTED
Alimera Sciences, Inc.
ALIM
| $15.8M | 12.53% | 4,051,072 +51,613 | +1% | +$201K |
|
|
4
Galapagos
GLPG
$2.07B
| $12.7M | 10.05% | 393,634 +131,764 | +50% | +$4.24M |
|
|
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
| $9.72M | 7.71% | +1,976,342 | New | +$9.72M |
|
6
Xoma
XOMA
$392M
| $6.1M | 4.84% | 253,770 +3,770 | +2% | +$90.7K |
|
7
TELA Bio
TELA
$70.5M
| $3.9M | 3.1% | 688,200 +370,418 | +117% | +$2.1M |
|
|
8
Nektar Therapeutics
NKTR
$568M
| $3.25M | 2.58% | +3,480,409 | New | +$3.25M |
|
|
9
Milestone Pharmaceuticals
MIST
$156M
| $2.62M | 2.08% | +1,462,296 | New | +$2.62M |
|
|
10
scPharmaceuticals
SCPH
$295M
| $2.24M | 1.78% | +446,776 | New | +$2.24M |
|
11
CalciMedica
CALC
$37.7M
| $2.17M | 1.72% | +522,602 | New | +$2.17M |
|
12
Anika Therapeutics
ANIK
$135M
| $1.55M | 1.23% | +60,949 | New | +$1.55M |
|
13
Rigel Pharmaceuticals
RIGL
$697M
| $1.54M | 1.22% | +1,040,241 | New | +$1.54M |
|
14
AYTU BioPharma
AYTU
$21.1M
| $1.44M | 1.14% | 472,469 | – | – |
|
|
15
Xeris Biopharma Holdings
XERS
$1.26B
| $1.32M | 1.05% | 598,086 -5,338,914 | -90% | -$11.8M |
|
16
Exagen
XGN
$217M
| $612K | 0.49% | 384,600 -285,084 | -43% | -$453K |
|
17
Adicet Bio
ACET
$59.9M
| $333K | 0.26% | +141,548 | New | +$333K |
|
18
Rezolute
RZLT
$619M
| $310K | 0.25% | 121,479 -2,647,177 | -96% | -$6.75M |
|
19
IO Biotech
IOBT
$104M
| $270K | 0.21% | 156,167 -1,509,870 | -91% | -$2.61M |
|
20
SCYNEXIS
SCYX
$34.9M
| $141K | 0.11% | 95,637 -1,259,549 | -93% | -$1.85M |
|
|
21
Amylyx Pharmaceuticals
AMLX
$836M
| – | – | -2,500,000 | Closed | -$36.8M |
|
22
Atea Pharmaceuticals
AVIR
$267M
| – | – | -839,514 | Closed | -$2.56M |
|
|
23
QuidelOrtho
QDEL
$1.95B
| – | – | -450,000 | Closed | -$33.2M |
|
|
ATYR
24
aTyr Pharma
ATYR
$527M
| – | – | -482,258 | Closed | -$680K |
|